NYSE$EPC
Edgewell Personal Care · Q1 2022 earnings
Q1 2022 earnings · · Investor relations
Briefing
Announced a net sales increase of 2.7%, or 2.5% organic, and updated the previously provided outlook for fiscal 2022 to include the Billie Acquisition.
Edgewell Personal Care reported a 2.7% increase in net sales to $463.3 million and a 2.5% increase in organic net sales for the first quarter of fiscal year 2022. GAAP EPS was $0.20, while adjusted EPS was $0.42, which included a $0.04 negative impact from the Billie acquisition. The company reaffirmed its fiscal year 2022 outlook, adjusting for the Billie acquisition and currency impacts.
- Net sales increased by 2.7% to $463.3 million, with organic net sales up by 2.5%.
- GAAP EPS was $0.20, compared to $0.32 in the prior year quarter.
- Adjusted EPS was $0.42, which included a $0.04 negative impact from the Billie acquisition.
- The company returned $33 million to shareholders through share repurchases and dividends.
Headline financials
Revenue & EPS history
Edgewell · Revenue · Quarterly
$463M
Revenue by segment
Edgewell · $391M total across 2 segments · Q1 2022
- Wet Shave$286M+2.5%73.2%
- Sun and Skin Care$105M+1.7%26.8%
Forward guidance
The Company is updating its previously provided outlook assumptions for fiscal 2022 to include the ten month impact of the Billie acquisition and the incremental negative impact of currency translation. Excluding these impacts, the current outlook is in-line with the previously provided outlook.
Tailwinds
- Reported net sales expected to increase mid-single digits.
- Organic sales expected to increase low-single digits.
- Adjusted effective tax rate expected to be in the range of 22% to 23%.
- Total depreciation and amortization expense is expected to be $93.5 million, including $9.0 million in incremental amortization expense related to the acquisition of Billie
- Free cash flow expected to be approximately 100% of non-GAAP net earnings
Headwinds
- Updated to include an estimated 400-basis point increase from the acquisition of Billie, net of Edgewell sales to Billie which were included in the previous outlook
- Updated to Include a 160-basis point negative impact from currency translation
- GAAP EPS anticipated to be in the range of $2.23 to $2.51
- Adjusted EPS anticipated to now be in the range of $2.74 to $3.02
- Adjusted EBITDA expected to now be in the range of $357 to $377 million
Historical earnings impact
How earnings announcements have historically affected this stock's price.
Avg. return before/after earnings
Based on 20 quarterly earnings reports · overlaid with Q1 2022
+0.2%
Avg return
Earnings day
+0.1%
Avg return
5 days after
-0.8%
Avg return
30 days after
56%
38 / 68 earnings
Positive
+20.1%
Q1 2020
Best reaction
-17.0%
Q2 2019
Worst reaction
| Quarter | Report date | Reaction (Day 0) | +5 days | +30 days |
|---|---|---|---|---|
| Q2 2026 | +2.2% | -13.9% | -13.1% | |
| Q1 2026 | -4.6% | +5.5% | -4.0% | |
| Q4 2025 | -2.7% | -10.8% | -8.0% | |
| Q2 2025 | -10.2% | -4.3% | -9.9% | |
| Q1 2025 | -9.5% | -5.8% | -2.5% | |
| Q4 2024 | -0.5% | -2.8% | +1.1% | |
| Q3 2024 | -0.2% | -0.7% | +5.8% | |
| Q2 2024 | +4.4% | +7.9% | +3.4% | |
| Q1 2024 | +5.6% | +6.6% | +2.8% | |
| Q4 2023 | -2.5% | +1.6% | -0.7% | |
| Q3 2023 | -2.8% | -2.1% | -2.1% | |
| Q2 2023 | +1.9% | +2.6% | -2.0% | |
| Q1 2023 | +4.7% | +5.7% | -3.8% | |
| Q4 2022 | +0.9% | +2.8% | +3.5% | |
| Q3 2022 | +2.6% | +4.0% | -3.9% | |
| Q2 2022 | -11.8% | -10.6% | -8.8% | |
| Q1 2022 | -11.0% | -15.1% | -17.0% | |
| Q4 2021 | +13.9% | +14.6% | +17.2% | |
| Q3 2021 | +8.0% | +8.8% | +0.6% | |
| Q2 2021 | +9.1% | +10.4% | +13.2% | |
| Q1 2021 | +0.6% | -2.7% | +1.5% | |
| Q4 2020 | +9.2% | +13.2% | +12.1% | |
| Q3 2020 | -7.8% | -5.0% | -1.0% | |
| Q2 2020 | +11.1% | +2.7% | +22.6% | |
| Q1 2020 | +20.1% | +10.4% | -2.1% | |
| Q4 2019 | -11.4% | -15.5% | -13.2% | |
| Q3 2019 | +7.5% | +2.2% | +2.8% | |
| Q2 2019 | -17.0% | -15.1% | -22.8% | |
| Q1 2019 | +6.6% | +10.0% | +9.1% | |
| Q4 2018 | -9.6% | -6.1% | -11.6% | |
| Q3 2018 | +2.8% | +2.4% | -1.3% | |
| Q2 2018 | -1.4% | +2.2% | +5.1% | |
| Q1 2018 | -4.5% | -4.4% | +0.8% | |
| Q4 2017 | -6.5% | -5.1% | -2.8% | |
| Q3 2017 | +2.5% | +3.3% | +2.2% | |
| Q2 2017 | +5.4% | +3.6% | +3.5% | |
| Q1 2017 | -1.4% | -1.7% | -2.4% | |
| Q4 2016 | +8.2% | +8.7% | +1.7% | |
| Q3 2016 | -5.4% | -2.9% | -5.9% | |
| Q2 2016 | -3.7% | — | — | |
| Q1 2016 | -0.2% | — | — | |
| Q4 2015 | -3.0% | — | — | |
| Q3 2015 | +0.4% | — | — | |
| Q2 2015 | +0.9% | — | — | |
| Q1 2015 | -1.6% | — | — | |
| Q4 2014 | -0.0% | — | — | |
| Q3 2014 | -0.3% | — | — | |
| Q2 2014 | +3.6% | — | — | |
| Q1 2014 | -0.6% | — | — | |
| Q4 2013 | +1.4% | — | — | |
| Q3 2013 | -2.5% | — | — | |
| Q2 2013 | +3.8% | — | — | |
| Q1 2013 | +2.8% | — | — | |
| Q4 2012 | +0.0% | — | — | |
| Q3 2012 | -13.5% | — | — | |
| Q2 2012 | -2.2% | — | — | |
| Q1 2012 | +2.3% | — | — | |
| Q4 2011 | -1.7% | — | — | |
| Q3 2011 | +1.0% | — | — | |
| Q2 2011 | +0.5% | — | — | |
| Q1 2010 | +0.3% | — | — | |
| Q1 2011 | +0.1% | — | — | |
| Q2 2010 | +1.5% | — | — | |
| Q4 2008 | +1.5% | — | — | |
| Q4 2010 | +1.5% | — | — | |
| Q3 2009 | +4.3% | — | — | |
| Q3 2010 | +4.3% | — | — | |
| Q4 2009 | +4.3% | — | — |
Discussion
Share your read of this quarter. Sign-in carries your eToro identity.
Join the conversation
Sign in with eToro to post your read of this quarter and vote on others'.
Sign in with eToro